4//SEC Filing
Finley John David 4
Accession 0001493152-25-006498
CIK 0001357459other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:56 PM ET
Size
8.2 KB
Accession
0001493152-25-006498
Insider Transaction Report
Form 4
Finley John David
DirectorCEO, CFO
Transactions
- Award
Restricted Stock Units
2025-02-11+40,000→ 40,000 total→ Common Stock (40,000 underlying) - Award
Stock Option (Right to Buy)
2025-02-11+47,000→ 47,000 totalExercise: $1.13Exp: 2035-02-11→ Common Stock (47,000 underlying)
Footnotes (3)
- [F1]The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period beginning on May 11, 2025, subject to the Reporting Person's continuous service through each such vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service through each such vesting date.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001851034
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:56 PM ET
- Size
- 8.2 KB